These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35280301)

  • 1. The Epidemiology and Phenotypes of Ocular Manifestations in Childhood and Juvenile Myasthenia Gravis: A Review.
    Heckmann JM; Europa TA; Soni AJ; Nel M
    Front Neurol; 2022; 13():834212. PubMed ID: 35280301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the histopathological findings in myasthenia gravis: Clues to the pathogenesis of treatment-resistance in extraocular muscles.
    Europa TA; Nel M; Heckmann JM
    Neuromuscul Disord; 2019 May; 29(5):381-387. PubMed ID: 31029532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial bioenergetics in ocular fibroblasts of two myasthenia gravis cases.
    Europa TA; Nel M; Lebeko MR; Heckmann JM
    IBRO Neurosci Rep; 2022 Jun; 12():297-302. PubMed ID: 35746973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
    Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Ocular Myasthenia Gravis.
    Fisher K; Shah V
    Curr Treat Options Neurol; 2019 Sep; 21(10):46. PubMed ID: 31559492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
    Mullaney P; Vajsar J; Smith R; Buncic JR
    Ophthalmology; 2000 Mar; 107(3):504-10. PubMed ID: 10711889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to treatment in pediatric ocular myasthenia gravis.
    Xu L; Castro D; Reisch JS; Iannaccone ST
    Muscle Nerve; 2020 Feb; 61(2):226-230. PubMed ID: 31650555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset.
    Popperud TH; Viken MK; Kerty E; Lie BA
    PLoS One; 2017; 12(10):e0186383. PubMed ID: 29036181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of patient-specific myocytes identifies altered gene expression in the ophthalmoplegic subphenotype of myasthenia gravis.
    Nel M; Prince S; Heckmann JM
    Orphanet J Rare Dis; 2019 Jan; 14(1):24. PubMed ID: 30696470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Whole Genome Sequencing in an African Subphenotype of Myasthenia Gravis to Generate a Pathogenetic Hypothesis.
    Nel M; Mulder N; Europa TA; Heckmann JM
    Front Genet; 2019; 10():136. PubMed ID: 30881381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune mediated myasthenia gravis in children, current concepts and new treatments: A narrative review article.
    Tavasoli A
    Iran J Child Neurol; 2024; 18(3):21-42. PubMed ID: 38988843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis in Hong Kong Chinese. 2. Paediatric disease.
    Wong V; Hawkins BR; Yu YL
    Acta Neurol Scand; 1992 Jul; 86(1):68-72. PubMed ID: 1519477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile Ocular Myasthenia Gravis: Presentation and Outcome of a Large Cohort.
    Vanikieti K; Lowwongngam K; Padungkiatsagul T; Visudtibhan A; Poonyathalang A
    Pediatr Neurol; 2018 Oct; 87():36-41. PubMed ID: 30197221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI evidence of extraocular muscle atrophy and fatty replacement in myasthenia gravis.
    Velonakis G; Papadopoulos VE; Karavasilis E; Filippiadis DK; Zouvelou V
    Neuroradiology; 2021 Sep; 63(9):1531-1538. PubMed ID: 34232334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA antigens and acetylcholine receptor antibody in the subclassification of myasthenia gravis in Hong Kong Chinese.
    Hawkins BR; Ip MS; Lam KS; Ma JT; Wy CL; Yeung RT; Dawkins RL
    J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):316-9. PubMed ID: 3958744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort.
    Fisher KS; Gill J; Todd HF; Yang MB; Lopez MA; Abid F; Lotze T; Shah VS
    Pediatr Neurol; 2021 May; 118():12-19. PubMed ID: 33684630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile myasthenia gravis in Norway: Clinical characteristics, treatment, and long-term outcome in a nationwide population-based cohort.
    Popperud TH; Boldingh MI; Rasmussen M; Kerty E
    Eur J Paediatr Neurol; 2017 Sep; 21(5):707-714. PubMed ID: 28457757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases.
    McCreery KM; Hussein MA; Lee AG; Paysse EA; Chandran R; Coats DK
    Binocul Vis Strabismus Q; 2002; 17(3):181-6. PubMed ID: 12171588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.